PDF] Oxidative Stress: A Pathogenic Mechanism for Niemann-Pick Type C Disease

Because NPC is mainly caused by the accumulation of free cholesterol, oxidized cholesterol derivatives produced by oxidative stress may contribute to the pathogenesis of the disease. Niemann-Pick type C (NPC) disease is a neurovisceral atypical lipid storage disorder involving the accumulation of cholesterol and other lipids in the late endocytic pathway. The pathogenic mechanism that links the accumulation of intracellular cholesterol with cell death in NPC disease in both the CNS and the liver is currently unknown. Oxidative stress has been observed in the livers and brains of NPC mice and in different NPC cellular models. Moreover, there is evidence of an elevation of oxidative stress markers in the serumof NPC patients. Recent evidence strongly suggests that mitochondrial dysfunction plays an important role in NPC pathogenesis and that mitochondria could be a significant source of oxidative stress in this disease. In this context, the accumulation of vitamin E in the late endosomal/lysosomal compartments in NPC could lead to a potential decrease of its bioavailability and could be another possible cause of oxidative damage. Another possible source of reactive species in NPC is the diminished activity of different antioxidant enzymes. Moreover, because NPC is mainly caused by the accumulation of free cholesterol, oxidized cholesterol derivatives produced by oxidative stress may contribute to the pathogenesis of the disease.

PDF) The pathogenesis of Niemann-Pick type C disease: A role for

A new regulatory mechanism of STARD1 in Niemann-Pick disease type

Frontiers Lysosomal and Mitochondrial Liaisons in Niemann-Pick

Revisiting carotenoids as dietary antioxidants for human health

N -acetylcysteine (NAC) in neurological disorders: mechanisms of

Diagnostic workup and management of patients with suspected

Frontiers The role of oxidative stress in the pathogenesis of

Cytokine profile and cholesterol levels in patients with Niemann

Intestinal immunoregulation: lessons from human mendelian diseases

Enzyme Replacement Therapy Can Reverse Pathogenic Cascade in Pompe

Roles for c-Abl in postoperative neurodegeneration

New Therapeutic Approaches to Inherited Metabolic Pediatric